Coronavirus information and guidance

Biomedicine technology and biotechnology

Co-expression of multiple gene products (proteins) within the same cell is critical for success in many areas of biomedicine and biotechnology. This can now be readily accomplished by using 2A co-expression technology, developed by the Ryan Laboratory.

This technology has been critical in strategies for:

  • using human gene therapies targeting cancer
  • producing induced human pluripotent stem cells for regenerative medicine
  • creating transgenic animals and plants with improved nutritional properties
  • producing high-value proteins for the pharmaceutical industry.